Insys Executives Are Sentenced to Prison Time, Putting Opioid Makers On Notice
U.S. pharmaceutical executives have been put on notice that they could be held criminally liable for fueling America’s epidemic of opioid addiction, after the founder of the drugmaker Insys was sentenced to five-and-a-half years in prison for masterminding a scheme to bribe doctors to prescribe a dangerous painkiller.
Alec Burlakoff, Insys’s former head of sales, received a 26-month sentence for the same charges. Michael Babich, the former chief executive, has been sentenced to two-and-a-half years.
The prison terms have been handed down as other opioid makers and distributors are being criminally investigated and prosecutors are aiming to hold executives accountable in a pharma industry that has frequently dismissed fines as a cost of doing business.
U.S. pharmaceutical executives have been put on notice that they could be held criminally liable for fueling America’s epidemic of opioid addiction, after the founder of the drugmaker Insys was sentenced to five-and-a-half years in prison for masterminding a scheme to bribe doctors to prescribe a dangerous painkiller.
Alec Burlakoff, Insys’s former head of sales, received a 26-month sentence for the same charges. Michael Babich, the former chief executive, has been sentenced to two-and-a-half years.
The prison terms have been handed down as other opioid makers and distributors are being criminally investigated and prosecutors are aiming to hold executives accountable in a pharma industry that has frequently dismissed fines as a cost of doing business.